Literature DB >> 30632109

Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.

Toshiyuki Yamamoto1.   

Abstract

Palmoplantar pustulosis (PPP) is a chronic inflammatory disorder characterized by sterile pustules predominantly involving the palms and soles. The purpose of this review was to describe the characteristics of Japanese PPP patients as PPP is frequently observed within the Japanese population. Most Japanese dermatologists consider PPP a distinct entity, and co-existence of PPP and psoriasis is rare; however, outside Japan, PPP is often considered to be palmoplantar psoriasis, and an extra-palmoplantar lesion associated with PPP is considered to be psoriasis. PPP frequently develops or exacerbates following focal infections such as tonsillitis, odontogenic infection, and sinusitis, either with or without arthralgia. Pustulotic arthro-osteitis (PAO) is a major comorbidity of PPP, most often affecting the anterior chest wall. In Japanese patients, PAO is frequently seen, whereas cases of SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome with symptoms other than PPP and sternocostoclavicular joint pain are extremely rare. A difference in incidence depending on race suggests that different genetic backgrounds may be responsible for susceptibility to these disorders. The treatment of focal infections often results in dramatic effects on cutaneous lesions, as well as joint pain. The characteristics of Japanese patients with PPP are female predominance, mostly smokers, rare co-existence with psoriasis, frequent association with PAO, almost no accompanying celiac disease, and closely associated with focal infection. PPP should be separately considered from palmoplantar psoriasis.

Entities:  

Mesh:

Year:  2019        PMID: 30632109     DOI: 10.1007/s40261-018-00745-6

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  3 in total

1.  Design and implementation of an adaptive confirmatory trial in Japanese patients with palmoplantar pustulosis.

Authors:  Richuan Zheng; Yoichi M Ito; Motonari Yunoki; Kazuki Minoda; Soyoku Nobeyama
Journal:  Contemp Clin Trials Commun       Date:  2022-05-27

Review 2.  Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.

Authors:  Toshiyuki Yamamoto
Journal:  Clin Pharmacol       Date:  2021-06-23

3.  Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis.

Authors:  T Yamamoto; K Fukuda; A Morita; T Kimura; H Morishima; R Goto; R Zheng; T Terui
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.